Two investment firms have acquired large stakes in global CRO Novotech, the Singapore-based company announced March 30. GIC ...

Novotech provides biotech to small and mid-sized pharma companies. GIC and Temasek have signed a binding agreement to acquire ...

Since TPG’s investment in 2017, the firm has raised its headcount tenfold to 3,000 employees and expanded its operations ...

The reinvestment by TPG Asia and investment from GIC and Temasek will allow Novotech to pursue further organic growth and ...

SINGAPORE] Clinical research and testing provider Novotech on Monday (Mar 31) announced that Temasek and GIC will acquire a ...

The two sovereign wealth funds have taken a “significant stake” in the clinical research business owned by the private equity ...

Temasek Holdings Pte and GIC Pte Ltd. will acquire a significant stake in Novotech Pty Ltd. to fuel growth and accelerate ...

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to ...

Temasek and GIC will acquire a significant stake in Novotech, whose ebitda has grown fivefold since TPG’s initial investment ...

Clinical Trial Growth & Future Outlook: Analysis of the 150+ industry-sponsored siRNA clinical trials conducted between 2020 and 2024, with a 79.5% CAGR reflecting significant industry investment.